David M. Reese is the Executive Vice President and Chief Technology Officer at Amgen Inc., a leading biotechnology company focused on developing innovative medicines. In his role, Dr. Reese is responsible for overseeing the company's research and development, digital, and information technology strategies. He plays a critical role in driving Amgen's mission to advance human health through cutting-edge science and technology. Prior to joining Amgen in 2005, Dr. Reese had an impressive career in academia and the pharmaceutical industry. He earned his M.D. from the University of California, San Francisco, and completed his residency and fellowship training at UCSF and the National Cancer Institute, respectively. Dr. Reese then joined the faculty at UCSF, where he conducted groundbreaking research on cancer biology and treatment. In 2000, he transitioned to the pharmaceutical industry, joining Genentech as a senior scientist before rising to the position of Senior Vice President of Research and Early Development. At Amgen, Dr. Reese has been instrumental in advancing the company's pipeline of innovative therapies. Under his leadership, Amgen has successfully developed and brought to market several groundbreaking medicines, including treatments for cancer, cardiovascular disease, and osteoporosis. Dr. Reese's strategic vision and scientific expertise have been key to Amgen's success in delivering life-changing therapies to patients worldwide. His role as Chief Technology Officer positions him to continue driving the company's growth and innovation in the years ahead.